Legislation Quick Search
03/02/2021 01:14 AM
Pennsylvania House of Representatives
https://www.legis.state.pa.us/cfdocs/Legis/CSM/showMemoPublic.cfm?chamber=H&SPick=20150&cosponId=20634
Share:
Home / House Co-Sponsorship Memoranda

House Co-Sponsorship Memoranda

Subscribe to PaLegis Notifications
NEW!

Subscribe to receive notifications of new Co-Sponsorship Memos circulated

By Member | By Date | Keyword Search


House of Representatives
Session of 2015 - 2016 Regular Session

MEMORANDUM

Posted: August 23, 2016 03:49 PM
From: Representative Ed Gainey
To: All House members
Subject: OPIOID PACKAGE (5)
 
Colleagues, as a co-chair of the Pennsylvania Heroin, Opioid Prevention & Education Caucus (PA-HOPE), I will introduce several legislative proposals, which, if enacted, will provide additional tools in our fight against opioid prescription drug misuse and abuse.

In an attempt to limit access to opioid drugs, several of my legislative proposals have similar content, and would amend The Controlled, Substance, Drug, Device and Cosmetic Act (3) ; another would create a directive for the Department of Health, and the last would amend the Public School Code. All five (5) of these proposals are laid out below.

I thank you in advance for joining me as a sponsor of these most important legislative proposals.



Document #1

Introduced as HB2334

Description: This legislation limits access to opioid drugs by amending The Controlled, Substance, Drug, Device and Cosmetic Act as follows:
           
(1)  Require practitioners to query the ABC-MAP system (prescription monitoring system) before prescribing, administering or dispensing an extended-release long-acting opioid analgesic in a non-abuse deterrent form to determine if any unusual prescribing pattern exists for the patient and note the reasons for the prescription in the patient’s medical records.






 
 

Document #2

Introduced as HB2336

Description: This legislation limits access to opioid drugs by amending The Controlled, Substance, Drug, Device and Cosmetic Act as follows:

(2)  Require practitioners to query the ABC-MAP system (prescription monitoring system) before prescribing, administering or dispensing a controlled substance listed on any schedule of control substances to determine if any unusual prescribing pattern exists for the patient and note the reasons for the prescription in the patient’s medical records, if the controlled substance intended to be prescribed, administered or dispensed is for outpatient use, and is an opiate or contains an opiate or opiate like compound that has a potential for abuse, psychological or physical dependence, and which poses a heightened risk to public health.
 
 

Document #3

Description: This legislation limits access to opioid drugs by amending The Controlled, Substance, Drug, Device and Cosmetic Act as follows:

(3)  Prohibit the issuance of prescriptions for extended release long-acting opioid analgesics in a non-abuse deterrent form for outpatient use, unless an opioid analgesic in an abuse deterrent form or another drug or substance is not available as a substitute for treatment. 

 
 

Document #4

Introduced as HB2335

Description: This legislation limits access to opioid drugs by:

(4)  Directing the Department of Health to establish a voluntary non-opioid directive form.  The form could be used by a patient to indicate to all prescribers, practitioners, and health care facilities that the named patient has opted not to be administered an opioid drug or offered a prescription for an opioid drug, which does not have abuse-deterrent properties. 
 
 

Document #5

Introduced as HB2333

Description: This legislation limits access to opioid drugs by:

(5)  Amend §1547 of the Public School Code (Alcohol, Chemical and Tobacco Abuse Program) to require school districts, including charter schools, to expand their mandatory instructions in alcohol, chemical and tobacco abuse to include specific instruction on the misuse and abuse of prescription drugs and controlled substance.  School districts would collaborate with the Department of Drug and Alcohol Programs to develop the curriculum.